Literature DB >> 18498398

Prevalence of secondary chronic headaches in a population-based sample of 30-44-year-old persons. The Akershus study of chronic headache.

K Aaseth1, R B Grande, K J Kvaerner, P Gulbrandsen, C Lundqvist, M B Russell.   

Abstract

We studied secondary chronic headaches (> or = 15 days/month for at least 3 months) in a random sample of 30 000 persons aged 30-44 years. They received a mailed questionnaire. Those with self-reported chronic headache within the last month and/or year were invited to an interview and examination by a neurological resident. The criteria of the International Classification of Headache Disorders (ICHD-II) were applied. The questionnaire response rate was 71%, and the participation rate of the interview was 74%. Of the 633 participants, 298 had a secondary chronic headache. The 1-year prevalence of secondary chronic headache was 2.14%, i.e. chronic posttraumatic headache 0.21%, chronic headache attributed to whiplash injury 0.17%, post-craniotomy headache 0.02%, medication-overuse headache (MOH) 1.72%, cervicogenic headache 0.17%, headache attributed to chronic rhinosinusitis 0.33% and miscellaneous headaches 0.04%. The majority of those with ICHD-II-defined secondary chronic headache had MOH, while about one-third had other secondary headaches often in combination with MOH.

Entities:  

Mesh:

Year:  2008        PMID: 18498398     DOI: 10.1111/j.1468-2982.2008.01577.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  51 in total

Review 1.  Controversy over the classification of medication-overuse headache.

Authors:  Maurice B Vincent
Journal:  Curr Pain Headache Rep       Date:  2012-02

Review 2.  Medication overuse headache: a critical review of end points in recent follow-up studies.

Authors:  Knut Hagen; Rigmor Jensen; Magne Geir Bøe; Lars Jacob Stovner
Journal:  J Headache Pain       Date:  2010-05-16       Impact factor: 7.277

Review 3.  Medication-overuse headache: a perspective review.

Authors:  Maria Lurenda Westergaard; Signe Bruun Munksgaard; Lars Bendtsen; Rigmor Højland Jensen
Journal:  Ther Adv Drug Saf       Date:  2016-06-30

Review 4.  Medication-overuse headache: epidemiology, diagnosis and treatment.

Authors:  Espen Saxhaug Kristoffersen; Christofer Lundqvist
Journal:  Ther Adv Drug Saf       Date:  2014-04

5.  Headache: Medication overuse headache--seeking a management consensus.

Authors:  Michael Bjørn Russell
Journal:  Nat Rev Neurol       Date:  2014-05-27       Impact factor: 42.937

6.  Correlation Between Life Events and Quality of Life in Patients with Medication-Overuse Headache.

Authors:  Ebru Altintaş; Başak Karakurum Göksel; Nilgün Taşkintuna; Çağla Saritürk
Journal:  Noro Psikiyatr Ars       Date:  2015-07-07       Impact factor: 1.339

Review 7.  Prevalence of headache in Europe: a review for the Eurolight project.

Authors:  Lars Jacob Stovner; Colette Andree
Journal:  J Headache Pain       Date:  2010-05-16       Impact factor: 7.277

8.  Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine.

Authors:  Michael Bjørn Russell
Journal:  J Headache Pain       Date:  2011-03-27       Impact factor: 7.277

9.  A 4-year follow-up of patients with medication-overuse headache previously included in a randomized multicentre study.

Authors:  Knut Hagen; Claus Albretsen; Steinar T Vilming; Rolf Salvesen; Marit Grønning; Grethe Helde; Gøril Gravdahl; John-Anker Zwart; Lars Jacob Stovner
Journal:  J Headache Pain       Date:  2011-01-05       Impact factor: 7.277

10.  A face-to-face interview of participants in HUNT 3: the impact of the screening question on headache prevalence.

Authors:  Knut Hagen; John-Anker Zwart; Anne Hege Aamodt; Kristian Berhard Nilsen; Geir Bråthen; Grethe Helde; Marit Stjern; Erling A Tronvik; Lars Jacob Stovner
Journal:  J Headache Pain       Date:  2008-08-09       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.